Whilst this is a significant number, it means that around 50% of solid tumours in adults carry wild type TP53. In addition, many haematological malignancies, tumours associated with viral infection, as well as childhood cancers, seldom carry TP53 mutations. This evidence concerns the gene TP53 and childhood malignant neoplasm.